These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 12688021

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [What effect does losing weight have on hypertension?].
    Engeli S.
    MMW Fortschr Med; 2003 Jul 10; 145(27-28):44. PubMed ID: 14587188
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [New drugs for the treatment of obesity].
    Mustajoki P.
    Duodecim; 1999 Jul 10; 115(20):2191, 2193-4. PubMed ID: 11973921
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacologic therapies for obesity.
    Kaplan LM.
    Gastroenterol Clin North Am; 2010 Mar 10; 39(1):69-79. PubMed ID: 20202580
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacologic agents for the treatment of obesity.
    Mathys M.
    Clin Geriatr Med; 2005 Nov 10; 21(4):735-46, vii. PubMed ID: 16182086
    [Abstract] [Full Text] [Related]

  • 12. Long-term pharmacotherapy for obesity.
    Klein S.
    Obes Res; 2004 Dec 10; 12 Suppl():163S-6S. PubMed ID: 15687412
    [Abstract] [Full Text] [Related]

  • 13. Diets, drugs, exercise, and behavioral modification: Where these work and where they do not.
    Kushner R.
    Surg Obes Relat Dis; 2005 Dec 10; 1(2):120-2. PubMed ID: 16925226
    [No Abstract] [Full Text] [Related]

  • 14. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
    Verspohl EJ.
    Pharm Unserer Zeit; 2002 Dec 10; 31(3):300-7. PubMed ID: 12071127
    [No Abstract] [Full Text] [Related]

  • 15. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
    Richter WO.
    MMW Fortschr Med; 1999 Dec 09; 141(49-50):32-6. PubMed ID: 10726144
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacotherapy of obesity].
    Svendsen OL.
    Ugeskr Laeger; 2004 Oct 18; 166(43):3814-7. PubMed ID: 15544112
    [No Abstract] [Full Text] [Related]

  • 17. The new role of pharmacotherapy for weight reduction in obesity.
    Fernstrom MH, Fernstrom JD.
    Int J Clin Pract; 2002 Nov 18; 56(9):683-6. PubMed ID: 12469983
    [Abstract] [Full Text] [Related]

  • 18. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
    Toubro S.
    Ugeskr Laeger; 2007 Aug 13; 169(33):2619-22. PubMed ID: 17725907
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.